Evelo Biosciences, Inc.
EVLO · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$115 | -$122 | -$94 | -$85 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $3 | -$0 | -$0 |
| Stock-Based Comp. | $15 | $16 | $8 | $8 |
| Change in WC | -$10 | $2 | $8 | $3 |
| Other Non-Cash | $6 | $2 | $2 | $0 |
| Operating Cash Flow | -$101 | -$97 | -$73 | -$72 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $55 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$1 | -$1 | $52 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | $15 | $10 | $4 |
| Stock Issued | $85 | $82 | $55 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $0 | $1 |
| Financing Cash Flow | $82 | $98 | $65 | $5 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$21 | -$1 | -$9 | -$15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | $70 | $79 | $94 |
| End Cash | $49 | $70 | $70 | $79 |
| Free Cash Flow | -$102 | -$98 | -$74 | -$75 |